Baylor College of Medicine, Harvard University - Brigham and Women’s Hospital, Meridian Clinical Research, Duke University - Duke Human Vaccine Institute, Government of the United States of America - Vaccine Research Center, University of Texas Medical Branch-Galveston - The Sealy Institute for Vaccine Sciences, Government of the United States of America - VA Greater Los Angeles Healthcare System (GLA), Rutgers, The State University of New Jersey - New Jersey Medical School, Lynn Health Science Institute (Lynn Institute), DM Clinical Research - Texas Center for Drug Development (TCDD), DM Clinical Research, Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc. and Independent

Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Department of Surgery, Los Alamos National Laboratory - Theoretical Biology and Biophysics, Los Alamos National Laboratory - Theoretical Biology and Biophysics, Los Alamos National Laboratory - Theoretical Biology and Biophysics, Los Alamos National Laboratory - Theoretical Biology and Biophysics, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Los Alamos National Laboratory - Theoretical Biology and Biophysics, Los Alamos National Laboratory - Theoretical Biology and Biophysics, Moderna, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Los Alamos National Laboratory - Theoretical Biology and Biophysics and Duke University - Duke Human Vaccine Institute

Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Los Alamos National Laboratory - Theoretical Biology and Biophysics, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute

Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - School of Medicine, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute

Duke University - Duke Human Vaccine Institute, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Duke University - Duke Human Vaccine Institute, Beth Israel Deaconess Medical Center, University of Pennsylvania - Department of Microbiology, University of Pennsylvania - Department of Microbiology, Corporate Research Materials Lab, 3M Company, Infectious Disease Research Institute, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, BIOQUAL, BIOQUAL, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Government of the United States of America - Vaccine Research Center, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute

Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology - Department of Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Texas Biomedical Research Institute, Texas Biomedical Research Institute, Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., University of Maryland - School of Medicine, University of Maryland - School of Medicine, University of Maryland - School of Medicine, Duke University - Duke Human Vaccine Institute, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla Institute for Allergy and Immunology (LIAI), Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc. and MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard